Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
This grant funds research aimed at improving the predictability of food-drug and drug-drug interaction risks using an in vitro gastrointestinal dissolution model.
About this program
The grant focuses on enhancing the understanding of how food and other drugs interact with high-risk oral drug products. By utilizing an in vitro simulated gastrointestinal dissolution model, researchers aim to better predict the risks associated with these interactions. This research is crucial for ensuring the safety and efficacy of oral medications, particularly for vulnerable populations who may be at higher risk of adverse effects. The grant is intended for academic institutions, research organizations, and other entities engaged in pharmaceutical research. It encourages innovative approaches to studying drug interactions and aims to foster collaboration between researchers and industry stakeholders. By providing funding for clinical trials, the grant supports the development of safer drug products and improved therapeutic outcomes for patients.
Eligibility
Academic institutions, research organizations, and entities engaged in pharmaceutical research.
Requirements
- Must conduct research on high-risk oral drug products
- Clinical trial optional